Catalyst Wire Dossier Catalyst Wire Dossier

RUBRACA

RUCAPARIB · pharmaand GmbH
Drug timelines are a Plus or Pro feature.

24 regulatory and trial events tracked for RUBRACA, covering 2016-12-19 to 2026-08-19. Get the full timeline:

Most recent: EMA Authorised: Rubraca (rucaparib camsylate) — pharmaand GmbH

See pricing